27761397|t|Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study.
27761397|a|PURPOSE: Aim of the present study was to investigate potential impairment of non-motor areas in amyotrophic lateral sclerosis (ALS) using near-infrared spectroscopy (NIRS) and diffusion tensor imaging (DTI). In particular, we evaluated whether homotopic resting-state functional connectivity (rs-FC) of non-motor associated cortical areas correlates with clinical parameters and disease-specific degeneration of the corpus callosum (CC) in ALS. MATERIAL AND METHODS: Interhemispheric homotopic rs-FC was assessed in 31 patients and 30 healthy controls (HCs) for 8 cortical sites, from prefrontal to occipital cortex, using NIRS. DTI was performed in a subgroup of 21 patients. All patients were evaluated for cognitive dysfunction in the executive, memory, and visuospatial domains. RESULTS: ALS patients displayed an altered spatial pattern of correlation between homotopic rs-FC values when compared to HCs (p = 0.000013). In patients without executive dysfunction a strong correlation existed between the rate of motor decline and homotopic rs-FC of the anterior temporal lobes (ATLs) (rho = - 0.85, p = 0.0004). Furthermore, antero-temporal homotopic rs-FC correlated with fractional anisotropy in the central corpus callosum (CC), corticospinal tracts (CSTs), and forceps minor as determined by DTI (p < 0.05). CONCLUSIONS: The present study further supports involvement of non-motor areas in ALS. Our results render homotopic rs-FC as assessed by NIRS a potential clinical marker for disease progression rate in ALS patients without executive dysfunction and a potential anatomical marker for ALS-specific degeneration of the CC and CSTs.
27761397	33	62	amyotrophic lateral sclerosis	Disease	MESH:D000690
27761397	225	254	amyotrophic lateral sclerosis	Disease	MESH:D000690
27761397	256	259	ALS	Disease	MESH:D000690
27761397	525	560	degeneration of the corpus callosum	Disease	MESH:D061085
27761397	569	572	ALS	Disease	MESH:D000690
27761397	648	656	patients	Species	9606
27761397	796	804	patients	Species	9606
27761397	810	818	patients	Species	9606
27761397	838	859	cognitive dysfunction	Disease	MESH:D003072
27761397	921	924	ALS	Disease	MESH:D000690
27761397	925	933	patients	Species	9606
27761397	1057	1065	patients	Species	9606
27761397	1074	1095	executive dysfunction	Disease	MESH:D006331
27761397	1527	1530	ALS	Disease	MESH:D000690
27761397	1647	1650	ALS	Disease	MESH:D000690
27761397	1651	1659	patients	Species	9606
27761397	1668	1689	executive dysfunction	Disease	MESH:D006331
27761397	1728	1731	ALS	Disease	MESH:D000690

